This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Pamela Lockbaum
Introduction
Pamela Lockbaum is a notable inventor based in Moss Beach, California. She has made significant contributions to the field of cancer therapy through her innovative research and development. Her work focuses on improving patient outcomes by predicting responses to specific cancer treatments.
Latest Patents
Pamela Lockbaum holds a patent for a "Method for predicting response to epidermal growth factor receptor-directed therapy." This invention provides methods for determining or predicting response to cancer therapy in an individual. It represents a crucial advancement in personalized medicine, allowing for more tailored treatment plans.
Career Highlights
Pamela is currently employed at Amgen Inc., a leading biotechnology company. Her role involves extensive research and collaboration with other experts in the field. She has dedicated her career to enhancing the effectiveness of cancer therapies through innovative approaches.
Collaborations
Throughout her career, Pamela has worked alongside esteemed colleagues such as Sarah S Bacus and Xiao-Dong Yang. These collaborations have fostered a rich environment for innovation and have contributed to the advancement of cancer treatment methodologies.
Conclusion
Pamela Lockbaum's contributions to cancer therapy through her patented methods exemplify the impact of innovation in medicine. Her work continues to influence the field and improve patient care.